Public Joint-Stock Company "Pharmsynthez" (MISX: LIFE)
Health Care · Pharmaceuticals · RU
RUB—
— today · — 1Y
Public Joint-Stock Company "Pharmsynthez" (MISX: LIFE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $21.52M.
trading between 2.65 and 7.00.
Tweenvest scores Public Joint-Stock Company "Pharmsynthez" across four factors: quality 53/100, value 67/100, growth 0/100. Its strongest factor is value.
LIFE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.52M
- Revenue (TTM)
- $2.59M
- P/E
- —
- EPS
- -0.47
- Dividend yield
- —
- Beta (5Y)
- 0.09
- 52-week high
- RUB7.00
- 52-week low
- RUB2.65
- Avg volume (3M)
- —
- Shares outstanding
- 301.01M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Neurothera Labs Inc.TSXV: NTLX | $22.17M | CA$2.30 | -47.73% |
| Aytu BioPharma, Inc.NasdaqCM: AYTU | $22.01M | $2.02 | -0.25% |
| Accretion Pharmaceuticals LimitedNSEI: ACCPL | $21.70M | Rs188.95 | -7.06% |
| Accretion Nutraveda LimitedBSE: 544694 | $21.69M | Rs290.00 | -4.92% |
| Rubicon Organics Inc.TSXV: ROMJ | $21.31M | CA$0.45 | +2.27% |
| Philadelphia Pharmaceuticals CompanyASE: PHIL | $21.16M | JD2.00 | +5.26% |
| Coral Laboratories LimitedBSE: 524506 | $21.12M | Rs572.25 | +4.31% |
| MediPharm Labs Corp.TSX: LABS | $20.96M | CA$0.07 | 0.00% |
Figures last refreshed Oct 11, 2026.